PHARMACYTE BIOTECH, INC.

Profile

Company Names

PHARMACYTE BIOTECH, INC.
NUVILEX, INC.

Addresses

3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS, NV 89169

23046 AVENIDA DE LA CARLOTA, SUITE 600, LAGUNA HILLS, CA 92653

12510 PROSPERITY DRIVE, SUITE 310, SILVER SPRING, MD 20904-1643

Phone Numbers

(917) 595.2850
(917) 595-2850
917-595-2850

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$79,156,000.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-08-17 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity 
3
2021-08-23 
$70,000,000.00 
$70,000,000.00 
$0.00 
Equity 
2
2016-01-07 
$1,020,000.00 
$3,060,000.00 
$2,040,000.00 
Equity 
1
2012-04-27 
$1,136,000.00 
$3,500,000.00 
$2,364,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
M. 
ABECASSIS 
DIRECTOR
PHARMACYTE BIOTECH, INC.
ROBERT 
 
BOWKER 
DIRECTOR
NUVILEX, INC.
CRABTREE 
W. 
CRABTREE 
EXECUTIVE OFFICER, DIRECTOR
PHARMACYTE BIOTECH, INC.
GERALD 
W 
CRABTREE 
EXECUTIVE OFFICER, DIRECTOR
PHARMACYTE BIOTECH, INC.
GERALD 
W. 
CRABTREE 
EXECUTIVE OFFICER, DIRECTOR
NUVILEX, INC.
RICHARD 
M. 
GOLDFARB 
DIRECTOR
NUVILEX, INC.
PATRICIA 
 
GRUDEN 
EXECUTIVE OFFICER
NUVILEX, INC.
THOMAS 
 
LIQUARD 
DIRECTOR
PHARMACYTE BIOTECH, INC.
TIMOTHY 
 
MATULA 
DIRECTOR
NUVILEX, INC.
ROBERT 
F. 
RYAN 
DIRECTOR
CYPHERWORX, INC.   |  NUVILEX, INC.
JONATHAN 
L. 
SCHECHTER 
DIRECTOR
SYNAPTOGENIX, INC.   |  PHARMACYTE BIOTECH, INC.
JOSHUA 
N. 
SILVERMAN 
EXECUTIVE OFFICER, DIRECTOR
IROQUOIS CAPITAL LP   |  IROQUOIS CAPITAL OFFSHORE LTD   |  SYNAPTOGENIX, INC.   |  PETROS PHARMACEUTICALS, INC.   |  PHARMACYTE BIOTECH, INC.
RAYMOND 
CF 
TONG 
DIRECTOR
PHARMACYTE BIOTECH, INC.
CARLOS 
 
TRUJILLO 
EXECUTIVE OFFICER
WYNTRAIL FUND I LLC   |  WYNTRAIL FUND II LLC   |  PHARMACYTE BIOTECH, INC.
CARLOS 
A. 
TRUJILLO 
EXECUTIVE OFFICER, DIRECTOR
PHARMACYTE BIOTECH, INC.
KENNETH 
L 
WAGGONER 
EXECUTIVE OFFICER, DIRECTOR
PHARMACYTE BIOTECH, INC.
KENNETH 
L. 
WAGGONER 
EXECUTIVE OFFICER, DIRECTOR
NUVILEX, INC.   |  PHARMACYTE BIOTECH, INC.
WALKER 
R. 
WAYNE 
DIRECTOR
PHARMACYTE BIOTECH, INC.
ROBERT 
 
WEINSTEIN 
DIRECTOR
GREEN ENERGY MANAGEMENT SERVICES HOLDINGS, INC.   |  NEUROTROPE BIOSCIENCE, INC.   |  NEUROTROPE, INC.   |  ORTHOVESTMENTS, LLC   |  ORGANIC GROWTH HOLDINGS, INC   |  SYNAPTOGENIX, INC.   |  OBLONG, INC.   |  PHARMACYTE BIOTECH, INC.   |  TAO SYNERGIES INC.   |  XWELL, INC.
THOMAS 
C.K. 
YUEN 
DIRECTOR
PRIMEGEN BIOTECH LLC   |  PHARMACYTE BIOTECH, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-08-17 
2021-09-01
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-08-23 
2016-01-19
D
Link
PHARMACEUTICALS 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2016-01-07 
2013-12-27
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
NO REVENUES 
Equity 
2012-04-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GP NURMENKARI INC.
000153480
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
CHARDAN CAPITAL MARKETS LLC
120128